Vivo Capital Closes Oversubscribed $635 Million Fund to Invest in Public Healthcare Equities

Tuesday, September 11, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

PALO ALTO, Calif., Sept. 11, 2018 /PRNewswire/ -- Vivo Capital, a healthcare investment firm with offices in Palo

Alto, Beijing, Shanghai, and Taipei, announced the final closing of Vivo Opportunity Fund, L.P. (the "Fund") at an oversubscribed $635
million
, which brings the firm's total funds under management to more than $2.2 billion.

As a long-only public equity fund, the Fund plans to invest the capital in small to mid-cap public life sciences companies through follow-on financings, private placements, initial public offerings and block trades. Vivo intends to leverage its deep sector experience and fundamentals-driven approach from its prior funds that have invested in private and public therapeutics companies.   The Fund is focused on investing in companies bringing innovative products to the market.

Investors in the Fund include financial institutions, pension funds, endowments, foundations, and family offices.

About Vivo CapitalFounded in 1996, Vivo Capital is a healthcare investment firm focused on investing in and building high quality companies around the world. With more than $2.2 billion under management across multiple funds, Vivo Capital employs a unique multi-pronged strategy of identifying and working with companies that are developing and commercializing products and technology. Vivo Capital (http://www.vivocapital.com/) has offices in Palo Alto, Beijing, Shanghai and Taipei.

 

Cision View original content:http://www.prnewswire.com/news-releases/vivo-capital-closes-oversubscribed-635-million-fund-to-invest-in-public-healthcare-equities-300710097.html

SOURCE Vivo Capital



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store